首页 | 本学科首页   官方微博 | 高级检索  
     

胃癌组织中EN01、M2-PK蛋白表达及其临床意义
引用本文:倪田根,祝秉东,周欣,王娜,曾峰,关泉林. 胃癌组织中EN01、M2-PK蛋白表达及其临床意义[J]. 生物磁学, 2011, 0(20): 3871-3874
作者姓名:倪田根  祝秉东  周欣  王娜  曾峰  关泉林
作者单位:[1]兰州大学第一医院肿瘤外科,甘肃兰州730000 [2]兰州大学病原微生物研究所,甘肃兰州730000 [3]兰州大学第一医院病理科,甘肃兰州730000
基金项目:中央高校基本科研业务费专项资金资助(lzujbky-2010-143)
摘    要:目的:探讨胃癌组织中烯醇化酶-α(enolase-α,ENOD、肿瘤型丙酮酸激酶(tumor M2pyruvatekinase,M2-PK)的表达、相互关系及临床病理学意义。方法:应用免疫组织化学SP染色方法分别对55例胃癌组织和23例胃良性病变组织切片染色,观察胃癌组织和良性病变组织EN01、M2.PK的表达情况及分析两者临床病理关系。结果:胃癌组织中EN01阳性表达率为67.3%(37/55),明显高于胃良性病变组30.4%(7/23)(P〈0.01),其表达与胃癌分化程度、浸润深度、淋巴结转移及TNM分期均显著相关(均P〈0.05)。M2-PK在胃癌组织中的阳性表达率为78.2%(43/55),明显高于胃良性病变组织39.1%(9/23)(P〈0.01),其表达与胃癌分化程度、浸润深度均显著相关(均P〈0.05)。胃癌组织中EN01与M2-PK的表达呈正相关(r:=0.5729,P〈0.05)。结论:EN01和M2-PK的表达上调与胃癌的发生、发展可能有关,联合检测两种蛋白在肿瘤组织中的表达,对临床判断胃癌的预后有一定的指导意义。

关 键 词:胃癌  烯醇化酶-α肿瘤型丙酮酸激酶  免疫组化  肿瘤转移

Expressions and Clinical Significances of ENO 1 and M2-PK in Gastric Cancer
NI Tian-gen,ZHU Bing-dong,ZHOU Xin,WANG Na,ZENG Feng,GUAN Quan-lin. Expressions and Clinical Significances of ENO 1 and M2-PK in Gastric Cancer[J]. Biomagnetism, 2011, 0(20): 3871-3874
Authors:NI Tian-gen  ZHU Bing-dong  ZHOU Xin  WANG Na  ZENG Feng  GUAN Quan-lin
Affiliation:1 Department of Oncological Surgery, First Hospital of Lanzhou Universtiy, Lanzhou, 730000,China; 2 Institute of Pathogenic Biology of Lanzhou University, Lanzhou, 730000, China; 3 Department ofPathology, First Hospital ofLanzhou Universtiy, Lanzhou University, Lanzhou, 730000, China)
Abstract:Objeetive: To investigate the expression and clinicopathological significance of enolase-α (ENO1) and tumor M2 pyruvate kinase (M2-PK) in gastric cancer. Methods: The expression of ENO1 and M2-PK in 55 paraffin-embedded specimens of gastric cancer and 23 paraffin-embedded specimens of benign gastric tissue was detected by S-P irmnunohistochemistry. The correlation of ENO 1 expression to M2-PK expression, and their correlations to the clinicophathologic features of gastric cancer were analyzed. Results: The positive rate of ENO1 was significantly higher in gastric cancer than in benign gastric tissue (67.3% vs. 30.4%, P〈0.01), and closely related to differentiation grade ( P〈0.01), depth of invasion (P〈0.01), lymph node metastasis (P〈0.05) and TNM staging( P〈0. 05).The positive rate of M2-PK was significantly higher in gastric cancer than in benign gastric tissue (78.2%vs. 39.1%, P〈0.01), and closely related to differentiation grade ( P〈0.05), depth of invasion (P〈0.05) .The expression of ENO 1 was positively correlated to that of M2-PK (r=0.5729,P〈0.05) . Conclusion: The up-regulation of ENO1 and M2-PK expression may play important roles in the oncogenesis and progression of gastric cancer. Combined detection of the expression of ENO1 and M2-PK in gastric cancer may provide a significant parameter to judge the clinical prognostic of gastric cancer.
Keywords:Gastric cancer  Enolase-α  Tumor M2 pyruvate kinase  Immunohistochemistry
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号